1. Home
  2. DNLI vs UPST Comparison

DNLI vs UPST Comparison

Compare DNLI & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • UPST
  • Stock Information
  • Founded
  • DNLI 2013
  • UPST 2012
  • Country
  • DNLI United States
  • UPST United States
  • Employees
  • DNLI N/A
  • UPST N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • UPST Finance: Consumer Services
  • Sector
  • DNLI Health Care
  • UPST Finance
  • Exchange
  • DNLI Nasdaq
  • UPST Nasdaq
  • Market Cap
  • DNLI 4.5B
  • UPST 4.5B
  • IPO Year
  • DNLI 2017
  • UPST 2020
  • Fundamental
  • Price
  • DNLI $25.05
  • UPST $68.16
  • Analyst Decision
  • DNLI Strong Buy
  • UPST Hold
  • Analyst Count
  • DNLI 11
  • UPST 11
  • Target Price
  • DNLI $38.90
  • UPST $50.94
  • AVG Volume (30 Days)
  • DNLI 788.0K
  • UPST 9.0M
  • Earning Date
  • DNLI 11-06-2024
  • UPST 11-07-2024
  • Dividend Yield
  • DNLI N/A
  • UPST N/A
  • EPS Growth
  • DNLI N/A
  • UPST N/A
  • EPS
  • DNLI N/A
  • UPST N/A
  • Revenue
  • DNLI N/A
  • UPST $604,944,000.00
  • Revenue This Year
  • DNLI N/A
  • UPST $4.81
  • Revenue Next Year
  • DNLI $283.75
  • UPST $31.31
  • P/E Ratio
  • DNLI N/A
  • UPST N/A
  • Revenue Growth
  • DNLI 204.74
  • UPST 10.89
  • 52 Week Low
  • DNLI $14.56
  • UPST $20.60
  • 52 Week High
  • DNLI $33.33
  • UPST $86.07
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 37.93
  • UPST 61.97
  • Support Level
  • DNLI $26.17
  • UPST $65.15
  • Resistance Level
  • DNLI $33.33
  • UPST $72.78
  • Average True Range (ATR)
  • DNLI 1.64
  • UPST 5.00
  • MACD
  • DNLI -0.13
  • UPST 1.07
  • Stochastic Oscillator
  • DNLI 0.66
  • UPST 49.76

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About UPST Upstart Holdings Inc. Common stock

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.

Share on Social Networks: